Special Focus NIA-AA Preconference Symposia

Thursday, July 23, 2020 – Friday, July 24, 2020
Amsterdam, Netherlands

On This Page:

Third Annual NIA-AA Symposium: Enabling Precision Medicine for Alzheimer’s Disease Through Open Science

Thursday, July 23, 10 a.m.-6 p.m. and Friday, July 24, 8 a.m.-noon

This symposium will feature an array of translational research programs that integrate computational and experimental approaches to:

  1. Discover novel, disease-relevant targets and biomarkers.
  2. Develop next-generation animal models and target enabling tools.
  3. Support the development of new candidate therapeutics for a diverse portfolio of targets.
  4. Advance data-driven drug repositioning and combination therapy development.

The featured programs will include:

Intended Audience: Academic, biotech and pharmaceutical industry researchers with interest in target and biomarker discovery, preclinical and clinical drug development; computational biologists; data scientists; and open science advocates.

Agenda: View the agenda.

Registration: These events are complimentary, but require an RSVP to attend as seating is limited. Visit the Registration page.

Building on the Applied Science of Recruitment and Retention for Alzheimer's Disease and Related Dementia (AD/ADRD) Clinical Research

Friday, July 24, 2-6 p.m.

This symposium is designed to share best practices, identify gaps and support the development of an applied science of recruitment and retention to Alzheimer's Disease and Related Dementia (AD/ADRD) Clinical Research. The focus of the meeting is to:

  1. Document existing strategies used across different populations and contexts.
  2. Discuss current state of evidence-based practices.
  3. Set priority areas and goals to build on existing knowledge and address gaps.
  4. Ensure that recruitment strategies support ethical and inclusive approaches that address the broad spectrum of people with dementia.
  5. Discuss potential incentives to encourage reporting of best practices as they emerge.

Intended Audience: International experts, practitioners, and others invested and interested in participant recruitment and retention to AD/ADRD clinical research studies.

Agenda: The agenda will be posted at a later date.

Registration: These events are complimentary, but require an RSVP to attend as seating is limited. Visit the Registration page.

Become an ISTAART Member

Go beyond the conference — Network and collaborate year-round with a global community of leaders who are working to advance Alzheimer’s and dementia research.


Join the Conversation #AAIC22






News & Videos

Press Room

Contact Us

> 1200px
> 992px
> 768px
< 767px